Save
Invitation to ESGO 2025 in Rome
ESGO eAcademy, Fagotti Anna, 411169
Young Investigator Award
ESGO eAcademy, Nicole Concin, 411168
Best Runners Awards
ESGO eAcademy, Nicole Concin, 411167
Summary of the Congress
ESGO eAcademy, Nicole Concin, 411166
SUCCOR 10 Years: Vision A Decade After Radical Surgery As Primary Treatment For Cervical Cancer.
ESGO eAcademy, Nabil Manzour, 411161
Total Mesometrial Resection: Open Surgical Technique
ESGO eAcademy, Selcuk Erkilinc, 411155
Management of Late Urinary Complications
ESGO eAcademy, Giuseppe Vizzielli, 411165
Tumor Treating Fields (TTFields) therapy in platinum-resistant ovarian cancer: Results from the ENGOT-ov50 / GOG-3029 / INNOVATE-3 phase 3 study
ESGO eAcademy, Ignace Vergote, 411159
Boari Flap Technique In Urinari Reconstruction In Gynecological Cancer
ESGO eAcademy, Marta de la Cruz, 411153
Principle of Bladder Reconstruction and Urinary Diversion
ESGO eAcademy, Gwenael Ferron, 411164
Discussant
ESGO eAcademy, Domenica Lorusso, 411157
Laparoscopic Extraperitoneal Debulking Of Enlarged Para-Aortic Lymph Node In Patient With Endometrial Carcinoma Recurrence.
ESGO eAcademy, Andrea Ungredda, 411152
How to Manage Intraoperatively a Ureteral Injury?
ESGO eAcademy, Giovanni Aletti, 411163
Lenvatinib Plus Pembrolizumab Versus Chemotherapy As First-Line Therapy For Advanced Or Recurrent Endometrial Cancer: Primary Results Of The Phase 3 ENGOT-en9/LEAP-001 Study
ESGO eAcademy, Christian Marth, 411156
V-NOTES Sentinel Lymph Node Mapping For Endometrial Carcinoma
ESGO eAcademy, Selcuk Erkilinc, 411151
ESGO Gynae-Cancers Algorithms App Presentation
ESGO eAcademy, Enora Laas, 411144
The Role of Minimally Invasive Surgery in Cervical Cancer
ESGO eAcademy, Charalampos Theofanakis, 411147
Mucinous Ovarian Cancer, What We Have to Know Now and in the Future
ESGO eAcademy, Jonathan Ledermann, 411143
The Role of Neoadjuvant Chemotherapy in the Management of Cervical Cancer
ESGO eAcademy, Michael Halaska, 411146
Granulosa Cell Tumours, What We Have to Know Now and in the Future
ESGO eAcademy, Michael Friedlander, 411142
De-Escalation of Surgery for Cervical Cancer and Fertility-Sparing Management
ESGO eAcademy, Ane Gerda Eriksson, 411145
The Case of Small Cell Ovarian Tumours, What We Have to Know Now and in the Future
ESGO eAcademy, Isabelle Ray-Coquard, 411141
Training and Quality Assurance
ESGO eAcademy, Elisabeth Epstein, 411134
Systemic and Radiotherapeutic Management in Locally Advanced Vulvar Cancer – Who Should We Rather Not Operate
ESGO eAcademy, Sven Mahner, 411140
New Challenging Indications for Oncological Robotic Surgery
ESGO eAcademy, Jordi Ponce, 411137
Diagnostic and Surgical Management of the Vulva in Locally Advanced Vulvar Cancer – Who Should We Operate
ESGO eAcademy, Ignacio Zapardiel, 411139
MIS by Robotics on Interval Surgery for Ovarian Cancer
ESGO eAcademy, Fagotti Anna, 411136
Image-Guided Biopsy (Imaging Guidance, Sampling Methods)
ESGO eAcademy, Elisabeth Epstein, 411131
The Role of Robotics as a New Cervical Cancer Approach
ESGO eAcademy, Henrik Falconer, 411135
Project Introduction, General Recommendations
ESGO eAcademy, Daniela Fischerova, 411130
Whole Exome Sequencing In Vulvar Squamous Cell Carcinomas Identifies Impaired Prognosis Of Patients With TP53 Mutations Combined With CCND1 Gains
ESGO eAcademy, Núria Carreras-Dieguez, 411120
Quality of life for health care providers
ESGO eAcademy, Vesna I. Kesic, 411124
Endometriosis And Ovarian Cancer: Related Or Associated? Exploring Differences And Similarities
ESGO eAcademy, Giulia Dondi, 411118
Radiation and Surgical QI in Cervical Cancer
ESGO eAcademy, Christina Fotopoulou, 411127
The Role of Meaning and Dignity in the End-of-Life Care
ESGO eAcademy, Elisabeth Andritsch, 411123
Update On The Role Of Intraoperative Indocyanine Green Fluorescence Angiography In Preventing Anastomotic Leakage After Colorectal Resection In Cytoreductive Surgery For Advanced Ovarian Cancer
ESGO eAcademy, Livia Xhindoli, 411116
Should We Abandon Retroperitoneal Staging in Locally Advanced Cervical Cancer? CON
ESGO eAcademy, Berta Diaz-Feijoo, 411126
What Do You Need to Know about Sexuality Issues in Cancer Patients
ESGO eAcademy, Vesna Kesic, 411122
Should We Abandon Retroperitoneal Staging in Locally Advanced Cervical Cancer? PRO
ESGO eAcademy, Nadeem R. Abu-Rustum, 411125
Counselling for Fertility Preservation
ESGO eAcademy, Joachim Weis, 411121
Systemic Therapies in Relapse Setting for ‘Aggressive Histologies‘
ESGO eAcademy, Isabelle Ray-Coquard, 411111
Niraparib Maintenance Therapy Using An Individualised Starting Dose In Patients With Platinum-Sensitive Recurrent Ovarian Cancer (NORA): Final Overall Survival Analysis Of A Randomised, Double-Blind, Placebo-Controlled Phase 3 Trial
ESGO eAcademy, Xiaohua Wu, 411104
ViRP Signature Predicts Response To Treatment With Chemotherapy And Bevacizumab In Ovarian Cancer - A Translational Study Of The ICON-7 Trial”
ESGO eAcademy, Kristina Lindemann, 411103
Efficacy And Safety Of Bevacizumab Following Prior Anti-Angiogenic Treatment In Patients With Second-Line Platinum- Based Chemotherapy In Recurrent Ovarian Cancer – A Subgroup Analysis Of The AGO-OVAR 2.21 Phase III Trial
ESGO eAcademy, Anca Chelariu-Raicu, 411102
How Molecular Profiling Guides Medical Treatment
ESGO eAcademy, Domenica Lorusso, 411107
Which Efficient Therapies for Low-Ggrade ESS or AS and Miscellenous Rare Entities
ESGO eAcademy, Michael Friedlander, 411110
Multi-Omic Characterization Of Naïve Treatment Samples Of Epithelial Ovarian Cancer Addressed To Neoadjuvant Chemotherapy: An Hypothesis-Generating Study On Biomarkers Of Response To Platinum-Based Chemotherapy
ESGO eAcademy, Camilla Nero, 411100
The New FIGO Staging in the Modern Era of Molecular Profiling
ESGO eAcademy, Nicole Concin, 411106
Indication of Adjuvant or Peri Operative Therapy for LMS and other HG Uterine Sarcoma
ESGO eAcademy, Paolo Casali, 411109
Survival Outcomes Following Cytoreductive Surgery In Advanced Ovarian Cancer Patients: Prognosis Is Better Predicted By Completeness Of Resection Than By Disease Stage
ESGO eAcademy, Ioannis Kotsopoulos, 411099
Peritonectomy And Resection Of Mesentery During Visceral-Peritoneal Debulking (VPD) In Patients With Stage IIIC-IV Ovarian Cancer: A Phase I-II Trial
ESGO eAcademy, Matteo Marchetti, 411098
Molecular Profiling in Endometrial Cancer: Pitfalls and Challenges
ESGO eAcademy, Xavier Matias-Guiu, 411105
Principle of the Surgery in First Line and Relapse for Uterine Sarcoma
ESGO eAcademy, Jalid Sehouli, 411108
ESGO Gynae-Cancers Algorithms App Presentation
ESGO eAcademy, Schwameis Richard, 411096
Impact Of BRCA Mutation Status On Efficacy Of Atezolizumab Combined With Platinum-Based Chemotherapy And Maintenance Niraparib For Late-Relapsing Recurrent Ovarian Cancer: Subgroup Analysis Of The ENGOT-Ov41/GEICO 69-O/ANITA Phase 3 Trial
ESGO eAcademy, Michel Fabbro, 411088
Variant Histology Cervical Cancer: Approach to Definitive Radiation Therapy
ESGO eAcademy, Marisa Kollmeier, 411095
Vascular Challenges in Minimally Invasive Surgery
ESGO eAcademy, Reitan Ribeiro, 411092
Senaparib Maintenance In Newly Diagnosed Advanced Ovarian Cancer: FLAMES Study
ESGO eAcademy, Xiaohua Wu, 411087
Discussant
ESGO eAcademy, Charlie Gourley, 411086
How Clinical Management Guidelines Deviate from Common Tumour Types
ESGO eAcademy, David Cibula, 411094
The Leuven PARPi Benefit Test As Improved Approach For Prediction Of PARPi Benefit In The PAOLA-1/ENGOTov25 Trial
ESGO eAcademy, Loverix Liselore, 411085
HPV Independent Tumours - Recent Developments from a Pathologist´s Perspective
ESGO eAcademy, Simona Stolnicu, 411093
How We Prevent and Repair Vascular Complications?
ESGO eAcademy, José Ignacio Lorenzo, 411090
Assessment Of The Prognostic Impact Of The European Society Of Gynecologic Oncology Quality Indicators For Advanced Ovarian Cancer Surgery
ESGO eAcademy, Ane Gerda Eriksson, 411083
How Should We Treat Rrecurrent LGSOC?
ESGO eAcademy, Banerjee Susana, 411082
Updates in Pelvic and Urinary/Bowel Reconstruction after Pelvic Exenteration
ESGO eAcademy, Martina Fite, 411079
ADC Resistance
ESGO eAcademy, Toon Van Gorp, 411076
Adjuvant Therapy Decision Making for IGSOC
ESGO eAcademy, Charlie Gourley, 411081
Indication and Surgical Technique for LEER and Laterally Extended Pelvic Resection
ESGO eAcademy, Gwenael Ferron, 411078
Surgical Considerations for LGSOC
ESGO eAcademy, David Gershenson, 411080
From the Past to the Current Indications to Pelvic Exenteration
ESGO eAcademy, Bizzarri Nicolo, 411077
Immunotherapy Resistance
ESGO eAcademy, Iain McNeish, 411074
Modified Minimally Invasive Versus Open Radical Hysterectomy In Early-Stage Cervical Cancer: Interim Analysis Of A Multicenter, Prospective, Randomized Controlled Clinical Trial.
ESGO eAcademy, Tao Zhu, 410999
Cost-Effectiveness Analysis Of Simple Hysterectomy Compared To Radical Hysterectomy For Early Cervical Cancer From The CCTG CX.5 “SHAPE” Phase III Clinical Trial
ESGO eAcademy, Janice Kwon, 411073
Real-World Impact Of Surgical Clinical Trials In Gynecological Oncology: An Interrupted Time Series Analysis In France
ESGO eAcademy, Floriane Jochum, 411072
Value Of FDG-PET/CT For Staging Of Locally Advanced Cervical Cancer
ESGO eAcademy, Marc Barahona Orpinell, 411071
Surgery-Class D Radical Hysterectomy
ESGO eAcademy, David Cibula, 411065
Cervical Cancer
ESGO eAcademy, Mansoor Raza Mirza, 411062
Health-Related Quality Of Life In Patients With FRa Positive Platinum-Resistant Ovarian Cancer Treated With Mirvetuximab Soravtansine Vs. Investigator’s Choice Chemotherapy: Analysis From The Phase 3 MIRASOL Trial
ESGO eAcademy, Yolanda Garcia Garcia, 411070
The Role Of VY Flap Reconstruction In Vulvar Cancer Patients: A Multicenter Retrospective Study
ESGO eAcademy, Tullio Golia D'Augè, 411069
Chemo-Concurrent Radiation Therapy
ESGO eAcademy, Marisa Kollmeier, 411064
Endometrial Cancer
ESGO eAcademy, Christian Marth, 411061
Three-Dimensional Transvaginal Ultrasound Vs Magnetic Resonance Imaging For Preoperative Staging Of Deep Myometrial Invasion In Patients With Endometrial Cancer: A Preliminary Results.
ESGO eAcademy, Giulia Spagnol, 411068
Exploring The Influence Of Volume Center On Surgical Outcomes In The Management Of Early-Stage Endometrial Cancer: A Subanalysis Of The SENECA Study.
ESGO eAcademy, Felix Boria, 411067
NACTH
ESGO eAcademy, sudeep gupta, 411063
The Oncologic Outcomes Of Focal, Substantial, Or No Lymphovascular Space Invasion In Node Negative FIGO 2009 Stage I Endometrioid Endometrial Adenocarcinoma: A Multicenter Retrospective Cohort Study
ESGO eAcademy, Christian Dagher, 411066
Ovarian Cancer
ESGO eAcademy, Nicoletta Colombo, 411060
Treatment Of Recurrent Inguinofemoral Lymphocele By ICG Mapping Of Lymphatic Leakage: A Case Report And Literature Review
ESGO eAcademy, Melanie Schubert, 411051
Still Looking for the Gear to Bring Immunotherapy in the Ovarian Cancer Treatment
ESGO eAcademy, Isabelle Ray-Coquard, 411054
Total Pelvic Exenteration In Recurrent Vulvar Cancer Step By Step
ESGO eAcademy, Sara Iacoponi, 411050
Total Pelvic Exenteration With Radical Vulvectomy And Anorectal Amputation In 10 Steps.
ESGO eAcademy, Elodie Gauroy, 411049
Have We Reached the Ceiling in the Treatment of Metastatic/Recurrent Cervical Cancer?
ESGO eAcademy, Ana Oaknin, 411053
Pattern of Recurrence According to the Molecular Classification
ESGO eAcademy, Elisabeth Epstein, 411057
Vulvo-Vaginal Reconstruction In Neoplastic Disease
ESGO eAcademy, Nadia Veiga Canuto, 411048
Presentation of 1 Case Report
ESGO eAcademy, Alexandros Rodolakis, 411055
Leading a Paradigm Shift in the Treatment of Advanced/Recurrent Endometrial Cancer
ESGO eAcademy, Christian Marth, 411052
Composite Total Pelvic Exenteration In Vulvar Cancer Recurrence.
ESGO eAcademy, Sandra Herrero, 411047
Laparoscopic En-Bloc Resection Of The Pelvis Sec. Hudson-DellePiane With Concomitant Rectosigmoid Anastomosis For Stage IIIC Ovarian Cancer
ESGO eAcademy, Orazio De Tommasi, 411040
Double Hepatic Segmentectomy Assisted With ICG For Recurrence Of Ovarian Cancer.
ESGO eAcademy, Sergi Gonzalez, 411039
Robotic Sentinel Lymph Node Technique In Apparent Early Ovarian Cancer (ICG)
ESGO eAcademy, Victor Lago, 411038

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings